Clinical Report: Long-term neuropsychiatric impairment linked to chronic use of tiletamine-infused e-cigarettes
Overview
This case study describes a 22-year-old man who developed significant neuropsychiatric symptoms after chronic use of tiletamine-containing e-cigarettes. Symptoms included gait instability, dysarthria, and emotional instability.
Background
The emergence of new psychoactive substances, particularly in e-cigarettes, poses significant challenges for public health and clinical practice. Tiletamine, a dissociative anesthetic not approved for human use, has been reported as an adulterant in e-cigarettes, raising concerns about its potential neuropsychiatric effects.
Data Highlights
No numerical or trial data were provided in the source material.
Key Findings
A 22-year-old man developed progressive neuropsychiatric symptoms after chronic use of tiletamine-containing e-cigarettes.
Symptoms included gait instability, dysarthria, choking on liquids, hand tremor, and emotional instability.
Brain MRI and electromyography showed no structural abnormalities, while electroencephalography indicated functional brain involvement.
Symptoms persisted after cessation of tiletamine use, indicating potential dependence-related features.
Comprehensive treatment led to gradual improvement of symptoms over one month.
Clinical Implications
Healthcare providers should be aware of the potential for neuropsychiatric dysfunction associated with the use of tiletamine-containing e-cigarettes.
Conclusion
This case highlights the need for increased awareness of the neuropsychiatric risks associated with tiletamine in e-cigarettes and the importance of comprehensive treatment for affected individuals.
